Skip to main content
. 2014 Oct 23;11(1):99–104. doi: 10.3892/mmr.2014.2753

Figure 5.

Figure 5

MLT decreases MAPK activation in the artery wall. Western blot analysis of (A) ERK, (B) p38 and (C) JNK activation using phosphospecific antibodies. *P<0.05 vs. control group; #P<0.05 vs. AS group. Each assay was repeated three times. ERK, extracellular regulated protein kinase; JNK, c-Jun N-terminal kinase; p-, phosphorylated; MAPK, mitogen-activated protein kinase; Con, control; AS, atherosclerosis model group; MLT, melatonin-treated AS group.